Mechanisms of NO/cGMP-dependent vasorelaxation

Circ Res. 2000 Oct 27;87(9):825-30. doi: 10.1161/01.res.87.9.825.

Abstract

Both cGMP-dependent and -independent mechanisms have been implicated in the regulation of vascular tone by NO. We analyzed acetylcholine (ACh)- and NO-induced relaxation in pressurized small arteries and aortic rings from wild-type (wt) and cGMP kinase I-deficient (cGKI(-/-)) mice. Low concentrations of NO and ACh decreased the spontaneous myogenic tone in wt but not in cGKI(-/-) arteries. However, contractions of cGKI(-/-) arteries and aortic rings were reduced by high concentrations (10 micromol/L) of 2-(N:, N-diethylamino)-diazenolate-2-oxide (DEA-NO). Iberiotoxin, a specific blocker of Ca(2+)-activated K(+) (BK(Ca)) channels, only partially prevented the relaxation induced by DEA-NO or ACh in pressurized vessels and aortic rings. DEA-NO increased the activity of BK(Ca) channels only in vascular smooth muscle cells isolated from wt cGKI(+/+) mice. These results suggest that low physiological concentrations of NO decrease vascular tone through activation of cGKI, whereas high concentrations of DEA-NO relax vascular smooth muscle independent of cGKI and BK(Ca). NO-stimulated, cGKI-independent relaxation was antagonized by the inhibition of soluble guanylyl cyclase or cAMP kinase (cAK). DEA-NO increased cGMP to levels that are sufficient to activate cAK. cAMP-dependent relaxation was unperturbed in cGKI(-/-) vessels. In conclusion, low concentrations of NO relax vessels by activation of cGKI, whereas in the absence of cGKI, NO can relax small and large vessels by cGMP-dependent activation of cAK.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholine
  • Animals
  • Aorta
  • Cyclic AMP / analysis
  • Cyclic GMP / analysis
  • Cyclic GMP / pharmacology*
  • Cyclic GMP-Dependent Protein Kinases / deficiency*
  • Hydrazines
  • In Vitro Techniques
  • Male
  • Mice
  • Muscle, Smooth, Vascular / drug effects*
  • Muscle, Smooth, Vascular / enzymology
  • Nitric Oxide / pharmacology*
  • Nitrogen Oxides
  • Peptides / pharmacology
  • Vasodilation / drug effects*

Substances

  • Hydrazines
  • Nitrogen Oxides
  • Peptides
  • Nitric Oxide
  • iberiotoxin
  • 1,1-diethyl-2-hydroxy-2-nitrosohydrazine
  • Cyclic AMP
  • Cyclic GMP-Dependent Protein Kinases
  • Cyclic GMP
  • Acetylcholine